Nemzeti Influenza Pandémiás Terv

Objectives

Hungary’s National Influenza Pandemic Plan provides a national, whole-of-society framework for preparedness, alert, response, post-peak recovery and post-pandemic review in the event of a novel influenza virus with sustained human-to-human transmission. It aims to reduce transmission, illness, complications and deaths while preserving essential health services, public administration, critical infrastructure, social order and economic functioning.[1][2][3]

• Coordinate preparedness and response across government, health services, businesses, civil society, families and individuals, linking national, regional and local action to disaster-protection arrangements and international partners.[4][5]
• Apply World Health Organization pandemic phases, from preparedness through community transmission, national epidemic stages, post-peak conditions, possible subsequent waves and return to seasonal influenza patterns.[6][7]
• Contain early outbreaks locally where feasible and, if containment cannot be sustained, delay spread to create time for vaccination, treatment, resource mobilisation and wider mitigation measures.[8]
• Protect vulnerable and priority groups through seasonal and pandemic vaccination planning, antiviral preparedness, clinical guidance, infection prevention and public information on hygiene, healthcare-seeking and home care.[9][10][11]
• Maintain continuity of essential services, including energy, water, transport, food supply, communications, banking, public security and defence, alongside the capacity of primary, outpatient, inpatient, emergency and social-care services.[3][12]
• Restore normal operations after a pandemic, address deferred care and long-term complications, replenish depleted stocks, assess the first wave and prepare for a possible subsequent wave.[13][14]

Implementation

Implementation combines central government leadership, phase-based operational planning, health-sector delivery, intersectoral continuity planning, surveillance, public communication and international reporting. The Government is responsible for designating leadership, coordinating sectors, ensuring legislation and resources, developing capacity and prioritising scarce resources; the Governmental Coordination Committee, its Operational Staff and epidemic-response bodies provide coordination during heightened response.[5][15]

• Maintain and test national, sectoral, regional, local, hospital and business pandemic plans; harmonise them with other emergency plans; review preparedness at least annually; and update plans following exercises, evaluations and changing World Health Organization or European guidance.[16][17][18]
• Assign public-health and clinical functions to the Ministry of Health, the National Public Health and Medical Officer Service, the National Centre for Epidemiology, regional and local public-health institutes, ambulance and patient-transport providers, laboratories and healthcare institutions.[19]
• Operate seasonal and enhanced pandemic surveillance, including sentinel general-practice reporting, laboratory characterisation, investigation of unusual respiratory clusters and zoonotic influenza, and intensified sampling when novel-virus transmission is suspected.[20][21][22]
• Report novel influenza events internationally through the International Health Regulations and European Union early-warning arrangements, while sharing information with the World Health Organization, European Commission, European Centre for Disease Prevention and Control and Member States.[23][24]
• Collect detailed epidemiological, clinical and virological information on the first 100 pandemic cases, use it to characterise transmission and severity, and subsequently rely more heavily on geographically aggregated sentinel surveillance while maintaining reporting of severe cases.[25][26][27]
• Prepare healthcare services for surge demand by expanding infectious-disease capacity, strengthening intensive-care, ventilation, diagnostic and laboratory capability, securing medicines and personal protective equipment, and postponing non-urgent care when capacity is exceeded.[28][29]
• Reorganise health-service areas, referral arrangements, bed capacity and workforce deployment during a health disaster; use trained volunteers, students and other support personnel where appropriate; and protect health workers through vaccination, infection control and workforce-contingency arrangements.[30][31][32]
• Implement proportionate population measures, including case and contact management, travel advice, restrictions on mass gatherings or educational institutions where necessary, support for home-based care, and vaccine and antiviral deployment according to professional priorities.[33][34][35]
• Deliver coordinated risk and crisis communication through professional, governmental, media, digital and community channels, using clear and consistent messages on risks, preventive behaviour, available care, vaccination and service-access changes.[36][37][38]
• Monitor intervention effectiveness, safety, acceptability, health-system pressure, resource use, absenteeism and wider social effects; evaluate pandemic vaccines, antiviral treatment and response measures, including cost-effectiveness after the response.[39][40][41][42]
• Plan resource requirements for vaccines, medicines, protective equipment and response measures; seek additional government funding where required; mobilise domestic reserves and, if necessary, request international technical assistance or stocks. The supplied material does not provide quantified budgets or funding allocations.[17][43][44]

Monitoring & Evaluation

The plan establishes a phased monitoring, surveillance, reporting and review system for influenza-pandemic preparedness, response, recovery and post-pandemic revision. It combines domestic epidemiological and virological surveillance, international notification, operational situation assessment, plan testing and periodic preparedness review, although many extracts do not define numerical performance thresholds or independent audit arrangements.[6][16][18]

• Monitor seasonal influenza from epidemiological week 40 to week 20 of the following year through designated general practices covering approximately 20% of the population, supported by laboratory testing, antiviral-resistance testing where necessary, regional laboratory reagents and links to European and global surveillance networks.[20][21]
• Analyse influenza-like illness frequency and geographical distribution, investigate unusual clusters of respiratory illness or deaths, identify possible animal-origin influenza infections, and communicate findings and prevention advice to professionals, the public and decision-makers.[20][21]
• Publish weekly influenza situation updates by noon each Wednesday through national epidemiological and public-health websites, and report national data to European and World Health Organization surveillance systems.[21]
• Submit annual pandemic-preparedness reports to the national defence and security coordination body, prepared by the Ministry of Health’s Defence Office.[45]
• Notify the World Health Organization of novel influenza-virus events that may create an international public-health risk, through the national International Health Regulations information centre.[23]Report relevant communicable-disease threats through the European Union Early Warning and Response System and coordinate measures with the European Commission, the European Centre for Disease Prevention and Control and Member States.[24]
• Assess the epidemiological situation against the World Health Organization pandemic phases, including post-peak, subsequent-wave and post-pandemic conditions, to determine the level and implementation of response measures.[6][7]
• Test and evaluate national plans through exercises, maintain them in alignment with sectoral, business, hospital, emergency and disaster plans, and update them as required.[16]
• Review the national epidemiological situation, preparedness tasks and legal framework at least twice yearly through the Epidemiological Defence Working Committee, while assessing preparedness levels, priority plans and intervention effectiveness.[17]
• Strengthen surveillance in affected phases to identify, investigate and report cases and clusters rapidly, including sentinel surveillance outside the usual influenza season where required.[22]Collect detailed epidemiological, clinical and virological information on the first 100 cases, maintain a central database at the National Centre for Epidemiology, and report findings to the World Health Organization and European Union.[46][25]
• Shift from individual detailed reporting to geographically aggregated clinical and virological sentinel-surveillance data once the objectives of first-case investigation have been achieved, while continuing individual reporting for severe cases.[26][27]
• Monitor treatment and vaccination effectiveness, antiviral consumption against planned use, antibiotic susceptibility in bacterial complications, health-system pressure, workforce absence, service interruptions and availability of essential medicines, vaccines, protective equipment, staff, beds and supplies.[40][34]
• Review hospital pandemic and disaster plans, infectious-disease and intensive-care capacity, staffing, reassignable beds, material conditions, clinical guidance and communication plans through competent public-health authorities.[47][48][11]
• Evaluate post-peak and post-pandemic epidemiological outcomes, deaths, vaccine and antiviral use, response effectiveness, acceptability, safety and cost-effectiveness; publish assessments, report lessons to the health minister and use findings to amend plans.[13][49][41][42]
• Review the national plan and preparedness at least annually against European Centre for Disease Prevention and Control and World Health Organization guidance and indicators, identify improvement tasks and report on measure effectiveness.[18]

Costing & Financing

The plan recognises that an influenza pandemic can create major health-system, social and economic costs, including reduced gross domestic product, workforce absence, disruption to essential services, and increased expenditure on treatment, prevention and sickness benefits. It requires forward planning for resources and budget support, but the supplied material provides no quantified budget, unit cost, financing total, funding gap or economic assumption.[4][2]

• Identify and allocate the institutional, material and human resources required for preparedness, containment and response, and make the costs of prevention, containment and associated budget-support needs predictable.[2]
• Develop mechanisms to mobilise and rapidly reallocate resources to territorial levels, assess preparedness priorities for vaccines and medicines, and seek additional government budgetary resources where necessary.[50][17]
• Prepare cost plans for pandemic-plan measures falling within the responsibilities of the national public-health service, including planning for personal protective equipment quantities and distribution.[43][48]
• Provide government financial cover for production of a new vaccine when pandemic conditions require population protection, while planning vaccine allocation, antiviral reserves, diagnostic materials, laboratory reagents, treatment capacity and workforce requirements.[51][52][53]
• Mobilise domestic human resources, stocks and State Health Reserve supplies during affected-country response, and seek international technical assistance or international stocks through the World Health Organization and European Commission if domestic capacity is insufficient.[44][32]
• Ensure budgetary coverage and contracting for seasonal influenza vaccination, while maintaining procurement, storage, logistics and programme planning responsibilities across the health system.[10]
• Seek reimbursement after the response for eligible additional costs incurred by participating responders that remain uncompensated, and replenish supplies released from the State Health Reserve.[13][49]
• Use cost-effectiveness as an explicit post-pandemic evaluation criterion for response measures, antiviral medicines and vaccination, without specifying monetary valuation methods or thresholds.[49][42]